Executive interview – VolitionRx

Executive interview – VolitionRx

An interview covering third quarter results and a business update with Cameron Reynolds, CEO of Volition, a multi-national life sciences company developing simple, easy to use blood-based cancer tests to accurately diagnose a range of cancers.


You may also be interested in these:

Consumer

BAT – H125 results highlights

Healthcare

Oryzon Genomics – executive interview

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free